Prevention of infectious complications in acute lymphoblastic leukemia.
D000208:Acute Disease; D000212:Acyclovir / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002404:Catheterization / Q000009:adverse effects; D002644:Chickenpox / Q000517:prevention & control; D006090:Gram-Negative Bacteria; D006562:Herpes Zoster / Q000517:prevention & control; D006801:Humans; D007114:Immunization; D007116:Immunization, Passive; D017053:Infection Control; D007945:Leukemia, Lymphoid / Q000150:complications*; D009181:Mycoses / Q000517:prevention & control; D011528:Protozoan Infections / Q000517:prevention & control; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014295:Trimethoprim; D013420:Sulfamethoxazole; D000212:Acyclovir